Marketing-authorisation holder
Ceft Biopharma s.r.o.
3 medicines in 3 countries, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ZEVALINKit per preparazione radiofarmaceutica | Ibritumomab tiuxetan (90y) | Italy | Authorised | |
| ZEVALIN 1,6 mg/ml, EQUIPO REACTIVO PARA LA PREPARACION DE UN RADIOFARMACO PARA PERFUSION1,6 mg · Equipo de reactivos para preparación radiofarmacéutica | Ibritumomab tiuxetan (90y) | Spain | Marketed | 2004 |
| Zevalin | Ibritumomab tiuxetan (90y) | EU (EMA) | Cancelled | 2004 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 1 | 1 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 0 | 1 | CompaniesAll medicines |
| Italy | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Therapeutic radiopharmaceuticalsVarious · ATC V10X
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- ceft biopharma
- ceft biopharma s r o
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 3
- Countries
- 3
- Roles
- Authorisation holder